Abstract
Background: The management of sarcomas of the jaws remains a challenge in the field of head and neck oncology. The difficult diagnosis often causes a poor prognosis and high mortality. As sarcomas comprise less than 1% of all head and neck malignancies, there are no prospective, randomized-controlled trials to guide management.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Oral and Maxillofacial Surgery
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
